Overview

Collate provides an AI-powered platform that automates the creation and management of documentation for drug development, medical devices, and diagnostics. It works by generating, organizing, and governing regulatory and quality documents while offering data discovery and governance tools to ensure high-quality data assets. It distinguishes itself by offering an end-to-end, life-sciences–focused solution that covers drug, device, and diagnostic workflows in one platform, reducing manual work and speeding up approvals. Its goal is to shorten development and regulatory timelines so researchers can focus on discovery and bring life-saving innovations to patients faster.

YC Company

Launched Recently

Simplify's Take

What believers are saying

• Pfizer's 20% manufacturing throughput gains validate AI documentation automation market demand.[5]
• UCSF ARPA-H funding accelerates open-source drug development, creating IND filing opportunities.[5]
• Moderna's AWS AI integration demonstrates enterprise adoption of automated quality control workflows.[5]

What critics are saying

• Pfizer's proprietary generative AI platform directly competes in manufacturing documentation automation.[5]
• FDA's DARRTS system with AI language models bypasses Collate's regulatory submission tools.[7]
• Open-source models from UCSF and Open Molecular Software Foundation commoditize documentation automation.[5]

What makes Collate unique

• Acquired MantleBio to deepen AI capabilities across entire drug development lifecycle.[1]
• Generative AI automates regulatory submissions, clinical trials, and quality management workflows.[2][3]
• AI Studio and SDK enable custom agents without external infrastructure dependencies.[8]

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$30M

Above

Industry Average

Funded Over

1 Rounds

Notable Investors:

Y Combinator

Notable Investors:

Y Combinator

$30,000,000

Seed

Jan 2025

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.

Seed Funding Comparison

Above Average

Industry standards

Ind Avg. $3.3M

$500k

$1.5M

$2M

$2.3M

$3M

$30M